Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1Lyudmila Bazhenova, Nofisat Ismaila, Greg Durm, et al.
Immunotherapy|July 3, 2026
Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysisNicolas Peruzzo, Gabriel Lenz, Rafael Alvim Pereira, et al.
Molecular Diagnosis & Therapy|November 2, 2021
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid TumorsKevin Chen, Misty D Shields, Pradeep S Chauhan, et al.
BMC Cancer|December 30, 2025
Different plasma exosome isolation methods generated distinct microRNA and protein profiles in healthy controls and patients with advanced prostate and lung cancerKapil K Avasthi, Brandon J Manley, Bruna Pellini, et al.
Clinical Lung Cancer|June 10, 2025
Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1-Negative Squamous Cell Lung Carcinoma: A Systematic Review and Meta-AnalysisNicolas Peruzzo, Gabriel Lenz, Ted Akhiwu, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Trastuzumab Deruxtecan Combination Strongly Enhances Responses and Overcomes Sotorasib Resistance in <i>KRAS</i> <sup>G12C</sup> -Mutant NSCLCHilal Ozakinci, Bina Desai, Denise Kalos, et al.
Translational Lung Cancer Research|May 22, 2026
Pre-clinical efficacy of trastuzumab deruxtecan plus sotorasib in <i>KRAS<sup>G12C</sup></i> -mutant non-small cell lung cancer and exploratory HER2 profiling in human tumorsHilal Ozakinci, Bina Desai, Denise Kalos, et al.
Journal of Thoracic Disease|December 13, 2023
Osimertinib <i>vs.</i> afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an <i>EGFR</i> exon 19 deletion or exon 21 L858R mutationSophia Gilardone, Ram Thapa, José Laborde, et al.
The Laryngoscope|December 2, 2016
Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinomaBruna Pellini Ferreira, Mary Redman, Kelsey K Baker, et al.
Research Square|March 30, 2023
Pre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancerNicholas P Semenkovich, Pamela P Samson, Shahed N Badiyan, et al.
Pageof 5